Jan Henrik Terheyden

Muskaan Chopra, Lorenz Sparrenberg, Armin Berger et al.

Diabetic Retinopathy (DR) remains a leading cause of preventable blindness, with early detection critical for reducing vision loss worldwide. Over the past decade, deep learning has transformed DR screening, progressing from early convolutional neural networks trained on private datasets to advanced pipelines addressing class imbalance, label scarcity, domain shift, and interpretability. This survey provides the first systematic synthesis of DR research spanning 2016-2025, consolidating results from 50+ studies and over 20 datasets. We critically examine methodological advances, including self- and semi-supervised learning, domain generalization, federated training, and hybrid neuro-symbolic models, alongside evaluation protocols, reporting standards, and reproducibility challenges. Benchmark tables contextualize performance across datasets, while discussion highlights open gaps in multi-center validation and clinical trust. By linking technical progress with translational barriers, this work outlines a practical agenda for reproducible, privacy-preserving, and clinically deployable DR AI. Beyond DR, many of the surveyed innovations extend broadly to medical imaging at scale.

Maren Pielka, Tobias Schneider, Jan Terheyden et al.

We present an outline of the first large language model (LLM) based chatbot application in the context of patient-reported outcome measures (PROMs) for diabetic retinopathy. By utilizing the capabilities of current LLMs, we enable patients to provide feedback about their quality of life and treatment progress via an interactive application. The proposed framework offers significant advantages over the current approach, which encompasses only qualitative collection of survey data or a static survey with limited answer options. Using the PROBot LLM-PROM application, patients will be asked tailored questions about their individual challenges, and can give more detailed feedback on the progress of their treatment. Based on this input, we will use machine learning to infer conventional PROM scores, which can be used by clinicians to evaluate the treatment status. The goal of the application is to improve adherence to the healthcare system and treatments, and thus ultimately reduce cases of subsequent vision impairment. The approach needs to be further validated using a survey and a clinical study.